Click Therapeutics delivers safe and effective digital treatments to patients in need.
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 15, 2022 | Debt Financing | $15M | 1 | Silicon Valley Bank | — | Detail |
Oct 22, 2021 | Series B | $52M | 8 | Accelmed H.I.G. BioHealth Partners | — | Detail |
Dec 1, 2020 | Debt Financing | $30M | 1 | K2 HealthVentures | — | Detail |
Sep 11, 2020 | Funding Round | $500M | 1 | Boehringer Ingelheim | — | Detail |
Dec 11, 2018 | Funding Round | $302M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Silicon Valley Bank | Yes | Debt Financing |
Accelmed | Yes | Series B |
H.I.G. BioHealth Partners | Yes | Series B |
Boehringer Ingelheim | Yes | Funding Round |
Magellan Health Services | Yes | Convertable Note |
Health Catalyst Capital | — | Series B |
Hikma Ventures | — | Series B |
K2 HealthVentures | — | Series B |
Revelation Partners | — | Series B |
Ridgetop Health | — | Series B |
Click Therapeutics has acquired 1 organizations. Their most recent acquisition was ProGevity Neuroscience on Aug 6, 2012. They acquired ProGevity Neuroscience for 0.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Aug 6, 2012
ProGevity Neuroscience
|
Health Care | acquisition | — | Detail |